188 related articles for article (PubMed ID: 9973223)
1. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth.
Bagnato A; Salani D; Di Castro V; Wu-Wong JR; Tecce R; Nicotra MR; Venuti A; Natali PG
Cancer Res; 1999 Feb; 59(3):720-7. PubMed ID: 9973223
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells.
Bagnato A; Rosanò L; Di Castro V; Albini A; Salani D; Varmi M; Nicotra MR; Natali PG
Am J Pathol; 2001 Mar; 158(3):841-7. PubMed ID: 11238033
[TBL] [Abstract][Full Text] [Related]
3. ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro.
Salani D; Rosanò L; Di Castro V; Spinella F; Venuti A; Padley RJ; Nicotra MR; Natali PG; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():318S-321S. PubMed ID: 12193113
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 acts as a survival factor in ovarian carcinoma cells.
Del Bufalo D; Di Castro V; Biroccio A; Salani D; Rosanò L; Spinella F; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():302S-305S. PubMed ID: 12193109
[TBL] [Abstract][Full Text] [Related]
5. Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy.
Venuti A; Salani D; Manni V; Poggiali F; Bagnato A
FASEB J; 2000 Nov; 14(14):2277-83. PubMed ID: 11053249
[TBL] [Abstract][Full Text] [Related]
6. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium.
Ahmed SI; Thompson J; Coulson JM; Woll PJ
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):422-31. PubMed ID: 10745023
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelin-1 in neovascularization of ovarian carcinoma.
Salani D; Di Castro V; Nicotra MR; Rosanò L; Tecce R; Venuti A; Natali PG; Bagnato A
Am J Pathol; 2000 Nov; 157(5):1537-47. PubMed ID: 11073813
[TBL] [Abstract][Full Text] [Related]
8. Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells.
Bagnato A; Tecce R; Moretti C; Di Castro V; Spergel D; Catt KJ
Clin Cancer Res; 1995 Sep; 1(9):1059-66. PubMed ID: 9816080
[TBL] [Abstract][Full Text] [Related]
9. Endothelin expression and responsiveness in human ovarian carcinoma cell lines.
Moraitis S; Langdon SP; Miller WR
Eur J Cancer; 1997 Apr; 33(4):661-8. PubMed ID: 9274451
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
11. Endothelin receptor blockade inhibits the growth of human papillomavirus-associated cervical carcinoma.
Venuti A; Salani D; Cirilli A; Simeone P; Muller A; Flamini S; Padley R; Bagnato A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():310S-313S. PubMed ID: 12193111
[TBL] [Abstract][Full Text] [Related]
12. ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation.
Rosanò L; Di Castro V; Spinella F; Decandia S; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1132-5. PubMed ID: 16741063
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulation.
Owe-Young R; Schyvens CG; Qasabian RA; Conigrave AD; Macdonald PS; Williamson DJ
Br J Pharmacol; 1999 Jan; 126(1):103-10. PubMed ID: 10051126
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells.
Grimshaw MJ; Naylor S; Balkwill FR
Mol Cancer Ther; 2002 Dec; 1(14):1273-81. PubMed ID: 12516960
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW
Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991
[TBL] [Abstract][Full Text] [Related]
16. Paracrine regulation of ovarian cancer by endothelin.
Moraitis S; Miller WR; Smyth JF; Langdon SP
Eur J Cancer; 1999 Sep; 35(9):1381-7. PubMed ID: 10658531
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of ET(A)-receptor stimulation-induced increases in intracellular Ca2+ in SK-N-MC cells.
Heinroth-Hoffmann I; Vogelsang M; Schiewe P; Morawietz H; Holtz J; Pönicke K; Brodde OE
Br J Pharmacol; 1998 Nov; 125(6):1202-11. PubMed ID: 9863648
[TBL] [Abstract][Full Text] [Related]
18. Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: expression and effects on proliferation.
Takahashi K; Totsune K; Kitamuro T; Sone M; Murakami O; Shibahara S
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():35S-38S. PubMed ID: 12193050
[TBL] [Abstract][Full Text] [Related]
19. [Effect of endothelin-1 and its antagonists on the expression of endothelin receptors mRNA in HSC-T6 cells].
Zhang J; Zhang ZT; Wang Y; Wang P; Li JS; Zhou YZ
Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(21):1395-7. PubMed ID: 16318777
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
